Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
420 JPY | -0.71% | 0.00% | -40.17% |
Mar. 19 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
Mar. 19 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
Sales 2025 * | - | Sales 2026 * | 660M 4.24M | Capitalization | 28.82B 185M |
---|---|---|---|---|---|
Net income 2025 * | -3.3B -21.17M | Net income 2026 * | -3.53B -22.67M | EV / Sales 2025 * | - |
Net Debt 2025 * | 226M 1.45M | Net Debt 2026 * | 3.03B 19.49M | EV / Sales 2026 * | 48.3 x |
P/E ratio 2025 * |
-8.56
x | P/E ratio 2026 * |
-8.02
x | Employees | 29 |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 71.15% |
Latest transcript on SanBio Company Limited
1 day | -0.71% | ||
Current month | +1.20% | ||
1 month | +5.00% | ||
3 months | -30.46% | ||
6 months | -8.30% | ||
Current year | -40.17% |
Managers | Title | Age | Since |
---|---|---|---|
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Shinya Hirata
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Noboru Kotani
BRD | Director/Board Member | 67 | 13-02-28 |
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Toru Kawanishi
CHM | Chairman | 56 | 13-02-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 420 | -0.71% | 236 400 |
24-05-08 | 423 | -1.17% | 380,100 |
24-05-07 | 428 | -0.47% | 262,900 |
24-05-02 | 430 | +2.38% | 475,100 |
24-05-01 | 420 | +1.20% | 376,100 |
Delayed Quote Japan Exchange, May 09, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.17% | 187M | |
+2.73% | 108B | |
+10.08% | 105B | |
+1.57% | 23.46B | |
-12.05% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.24% | 17.19B | |
+6.12% | 13.99B | |
+35.97% | 12.53B |
- Stock Market
- Equities
- 4592 Stock